Systemic vascular effects of thrombin and thrombin receptor activating peptide in rats

Citation
T. Sicker et al., Systemic vascular effects of thrombin and thrombin receptor activating peptide in rats, THROMB RES, 101(6), 2001, pp. 467-475
Citations number
26
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
THROMBOSIS RESEARCH
ISSN journal
00493848 → ACNP
Volume
101
Issue
6
Year of publication
2001
Pages
467 - 475
Database
ISI
SICI code
0049-3848(20010315)101:6<467:SVEOTA>2.0.ZU;2-3
Abstract
The proteolytic enzyme thrombin activates its receptor by cleavage of a pep tide from the extracellular N-terminus. The newly generated N-terminus acts as a tethered ligand to activate the receptor. Receptor-mediated cellular effects of thrombin can be mimicked by synthetic peptides, which correspond to the amino acid sequence of the newly formed N-terminus. The aim of the present study was to investigate vascular effects of thrombin and the throm bin receptor activating peptide (TRAP: SFLLRN) in vitro and in vivo in rats . In precontracted rat aortic rings, both thrombin (0.3, 1, 3 U/ml) and TRA P (1, 3, 10, 20, 40 muM) induced endothelium-dependent relaxant responses. In anaesthetized rats, the mean arterial blood pressure (MAP) was measured continuously in the carotid artery by a pressure transducer. Thrombin and T RAP were administered as intravenous bolus injection via the femoral vein. Thrombin at doses of 3-100 U/kg, as well as TRAP at doses of 0.1 -0.6 mg/ k g iv, caused a reversible decrease in MAP. Administration of TRAP at doses of 0.3 and 0.6 mg/kg led to a triphasic response in most of the animals tre ated (50% and 75%, respectively), i.e. a short drop of MAP was followed by an increase and finally a longer lasting decrease in MAP. Pretreatment with the nitric oxide (NO)-synthase inhibitor N-G-nitro-L-arginine-methylester (L-NAME) suppressed the dose-dependent vasodilator effects of thrombin. Hep arin and hirudin also inhibited the hypotensive response to thrombin. The T RAP-induced triphasic reaction on MAP was not affected by the serotonin ant agonists ketanserin and tropisetron, as well as the aminopeptidase inhibito r amastatin. Pretreatment with L-NAME led to an inhibition of hypotension i nduced by TRAP at 0.1 mg/kg, as well as of the initial transient fall in bl ood pressure at doses of 0.3 and 0.6 mg/kg. The studies suggest that the th rombin- and TRAP-induced vasodilation in vitro and in vivo is in part due t o the release of endothelial NO. In the blood pressure response to TRAP, ad ditional effects seem to be involved. (C) 2001 Elsevier Science Ltd. All ri ghts reserved.